DALTON CHEKOKO WAMALWA

Summary

Country: Kenya

Publications

  1. pmc Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children
    Dalton C Wamalwa
    Department of Pediatrics, University of Nairobi, Nairobi, Kenya
    J Acquir Immune Defic Syndr 45:311-7. 2007
  2. pmc Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy
    Dalton C Wamalwa
    Department of Pediatrics, University of Nairobi, Nairobi, Kenya
    J Acquir Immune Defic Syndr 62:267-74. 2013
  3. pmc Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed
    Dalton Wamalwa
    Department of Paediatrics, University of Nairobi, Nairobi, Kenya
    Pediatr Infect Dis J 31:729-31. 2012
  4. pmc Evaluation of a single round polymerase chain reaction assay using dried blood spots for diagnosis of HIV-1 infection in infants in an African setting
    Bhavna H Chohan
    Department of Medical Microbiology, University of Nairobi College of Health Sciences, off Ngong Road, Nairobi, Box 19767 00202, Kenya
    BMC Pediatr 11:18. 2011
  5. pmc Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial
    Dalton C Wamalwa
    Department of Paediatrics University of Nairobi, Nairobi, Kenya
    J Int AIDS Soc 12:8. 2009
  6. pmc Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
    Dalton C Wamalwa
    Department of Paediatrics, University of Nairobi, Box 19676, Nairobi 00202, Kenya
    BMC Pediatr 10:33. 2010
  7. pmc Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya
    Nyawira Githinji
    Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya
    BMC Infect Dis 11:259. 2011

Research Grants

  1. Long-term efficacy of pediatric HAART
    DALTON CHEKOKO WAMALWA; Fiscal Year: 2010
  2. Long-term efficacy of pediatric HAART
    DALTON CHEKOKO WAMALWA; Fiscal Year: 2010

Collaborators

Detail Information

Publications7

  1. pmc Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children
    Dalton C Wamalwa
    Department of Pediatrics, University of Nairobi, Nairobi, Kenya
    J Acquir Immune Defic Syndr 45:311-7. 2007
    ....
  2. pmc Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy
    Dalton C Wamalwa
    Department of Pediatrics, University of Nairobi, Nairobi, Kenya
    J Acquir Immune Defic Syndr 62:267-74. 2013
    ..Therefore, understanding the long-term rate of virologic failure and drug resistance during prolonged antiretroviral treatment is important for establishing treatment strategies in African pediatric cohorts...
  3. pmc Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed
    Dalton Wamalwa
    Department of Paediatrics, University of Nairobi, Nairobi, Kenya
    Pediatr Infect Dis J 31:729-31. 2012
    ..Early HIV-1 diagnosis with antiretroviral therapy before symptomatic disease is critical for infant survival...
  4. pmc Evaluation of a single round polymerase chain reaction assay using dried blood spots for diagnosis of HIV-1 infection in infants in an African setting
    Bhavna H Chohan
    Department of Medical Microbiology, University of Nairobi College of Health Sciences, off Ngong Road, Nairobi, Box 19767 00202, Kenya
    BMC Pediatr 11:18. 2011
    ....
  5. pmc Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial
    Dalton C Wamalwa
    Department of Paediatrics University of Nairobi, Nairobi, Kenya
    J Int AIDS Soc 12:8. 2009
    ..abstract:..
  6. pmc Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
    Dalton C Wamalwa
    Department of Paediatrics, University of Nairobi, Box 19676, Nairobi 00202, Kenya
    BMC Pediatr 10:33. 2010
    ..Among children, early mortality following highly active antiretroviral therapy (HAART) remains high. It is important to define correlates of mortality in order to improve outcome...
  7. pmc Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya
    Nyawira Githinji
    Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya
    BMC Infect Dis 11:259. 2011
    ..In resource-limited settings, such as Kenya, access to CD4 testing is limited. Therefore, evaluation of less expensive laboratory diagnostics is urgently needed to diagnose immuno-suppression in children...

Research Grants6

  1. Long-term efficacy of pediatric HAART
    DALTON CHEKOKO WAMALWA; Fiscal Year: 2010
    ..This study will provide important information on effectiveness of HAART regimens being scaled up in resource-poor countries and help programs better plan for changes of drug regimens following treatment failure. ..
  2. Long-term efficacy of pediatric HAART
    DALTON CHEKOKO WAMALWA; Fiscal Year: 2010
    ..This study will provide important information on effectiveness of HAART regimens being scaled up in resource-poor countries and help programs better plan for changes of drug regimens following treatment failure. ..